Publications

• Fisher WE, Muscarella P, O’Dorisio TM, O’Dorisio MS, Kim JA, Doran TA, Sabourin CL, and Schirmer WJ. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery 1996;120(2):234-41.
• Melvin WS, Boros LG, Muscarella P, Brandes JL, Johnson JA, Fisher WE, Schirmer WJ, and Ellison CE. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo. Surgery 1997;121(4):392-297.
• Boros LG, Puigjaner JP, Cacante M, Lee WP, Brandes JL, Bassilian S, Yusuf FI, Williams RD, Muscarella P, Melvin WS and Schirmer WJ. Oxythiamine and Deydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997;57:4242-4248.
• Muscarella P, Melvin WS, Fisher WE, Foor J, Ellison EC, Herman JG, Schirmer WJ, Hitchcock CL, DeYoung BR and Weghorst CM. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: An analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res. 1998;58:237-240.
• Melvin WS, Buekers KS, Muscarella P, Johnson JA, Schirmer WJ and Ellison EC. Outcome analysis of long-term survivors following pancreaticoduodenectomy. J Gastrointest Surg. 1998;2(1):72-78.
• Fisher WE, Doran TA, Muscarella P, Boros LG, Ellison EC and Schirmer WJ. Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J National Cancer Institute. 1998;90(4):322-324.
• Fisher WE, Muscarella P, Boros LG and Schirmer WJ. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse. Surgery. 1998;123(3):315-320.
• Boros LG, Lee PW, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS and Ellison ES. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med Hypothesis. 1998;50(1):55-59.
• Muscarella P, Boros LG, Fisher WE, Rink C and Melvin WS. Oral Dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice. J Surgical Res. 1998;79:154-157.
• Fisher WE, Muscarella P, Boros LG and Schirmer WJ. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma. International J Pancreatology. 1998;24(3):169-180.
• Mailman MD, Muscarella P, Schirmer WJ, Ellison EC, O’Dorisio TM and Prior TW. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by the analysis of paraffin-embedded tissue. Clin Chem. 1999;45(1):29-34.
• Muscarella P, Needleman BJ, Goldstein AH and Steinberg SM. Laparoscopic repair of a subxiphoid incisional hernia following median sternotomy. Surgical Rounds. 2000;23(10):605-611.
• Muscarella P, Cook CH, and Praba AC. Food bolus obstruction of the small bowel occurring in association with a Meckel’s diverticulum. Surgical Rounds. 2001; 24(8):408-410.
• Cook CH, Muscarella P, Praba AC, Melvin WS and Martin LC. Reducing overtriage without compromising outcomes in trauma patients. Arch Surg. 2001; 136:752-756.
• Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin WS, Pour PM, Song H, Gold B, Batra SK and Weghorst CM. Identification and sequencing of the Syrian Golden hamster (Mesocrecitus auratus) p16INK4a and p15INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Gene. 2001;278:235-243.
• Gould JC, Needleman BJ, Ellison EC, Muscarella P, Schneider C, Melvin WS. Evolution of minimally invasive bariatric surgery. Surgery. 2002;132(4):565-572.
• Li J, Qin D, Knobloch TJ, Tsai M, Weghorst CM, Melvin, WS and Muscarella P. Expression and characterization of Syrian Golden hamster p16, a homologue of human tumor suppressor p16INK4A. Biochem Bioph Res Com. 2003;304:241-247.
• Cowgill SM and Muscarella P. The genetics of pancreatic cancer. Am J Surg. 2003;186(3):279-286.
• Li J, Weghorst CM, Tsutsumi M, Poi MJ, Knobloch TJ, Casto BC, Melvin WS, Tsai M, and Muscarella P. Frequent p16INK4A/CDKN2A Alterations in chemically induced Syrian Golden hamster pancreatic tumors. Carcinogenesis. 2004; 25(2):263-268.
• Go MR, Muscarella P, Needleman BJ, Cook CH, and Melvin WS. Endoscopic management of stomal stenosis after Roux-en-Y gastric bypass. Surg Endosc. 2004; 18(1): 56-59.
• Muscarella P, Cowgill S, DeRenne LA, and Ellison EC. Retroperitoneal benign cystic peritoneal mesothelioma. Surgery. 2004; 135(2):228-231.
• Li J, Melvin WS, Tsai M, and Muscarella P. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner. Biochemistry. 2004; 43(14):4394-4399.
• Go MR, Dundon JM, Karlowicz DJ, Domingo CB, Muscarella P, and Melvin WS. Delivery of radiofrequency energy to the lower esophageal sphincter improves symptoms of gastroesophageal reflux. Surgery. 2004; 136(4):786-794.
• Li J, Muscarella P, Hoon Joo S, Knobloch TJ, Melvin WS, Weghorst CJ, and Tsai M-D. Dissection of CDK4-Binding and transactivation activities of p34SEI-1 and comparison between functions of p34SEI-1 and p16INK4A. Biochemistry. 2005; 44(40):13246-13256.
• Tempero MA, Behrman S, Ben-Josef E, Benson AB 3rd, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW 2nd, Melvin WS, Muscarella P 2nd, Sasson AR, Shibata S, Shrieve DC, Talamonti MS, Tyler DS, Vickers SM, Warren RS, Willett C, Wolff RA; National Comprehensive Cancer Network.Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2005;(5):598-626.
• Acharya S, Butchbach MER, Sahenk Z, Wang H, Saji M, Carathers M, Ringel MD, Skipworth RJE, Fearon KCH, Hollingsworth MA, Muscarella P, Burghes AHM, Rafael-Fortney JA, and Guttridge DC. Dystrophin glycopreotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005;8(5):421-432.
• Li J, Zhu J, Melvin WS, Bekaii-Saab T, Chen C-S, and Muscarella P. A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth. J Gastrointest Surg. 2006;10(2):207-214.
• Kosuri K, Muscarella P, and Bekaii-Saab TS. Updates and controversies in the treatment of pancreatic cancer. Clin Adv Hematol Oncol. 2006;4(1):47-54.
• Mcguire L, Hefner K, Glaser R, Needleman B, Malarkey W, Dickinson S, Lemeshow S, Cook C, Muscarella P, Melvin WS, Ellison EC and Kiecolt-Glaser JK. Pain and wound healing in surgical patients. Ann Behav Med. 2006;31(2):47-54.
• Ellison EC, Sparks J, Verducci JS, Johnson JA, Muscarella P, Bloomston, M and MelvinWS. 50-year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg. 2006;202(6):897-905.
• Muscarella P. Re: Effect of jejunal and biliary decompression on postoperative complications and pancreatic leakage arising from pancreatojejunostomy after pancreatoduodenectomy. World J Surg. 2006;30(11):1990-1991.
• Bloomston M, Bekaii-Saab TS, Kosuri K, Cowgill SM, MelvinWS, Ellison EC and Muscarella P. Preoperative CA19-9 Is Most Predictive of Malignancy in Older Jaundiced Patients Undergoing Pancreatic Resection. Pancreas. 2006;33:246-249.
• Bloomston M, Ellison EC, Muscarella P, Al-Saif O, Martin E, MelvinWS and Frankel W. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer. Ann Surg Oncol. 2007;14(1):211-217..
• Bloomston M, Muscarella P, Shah MH, Frankel WL, Al-Saif O, Martin EW and Ellison EC. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg. 2006;10(10):1361-1370.
• Muscarella P. Re: Impact of Lymph Node Micrometastasis in Patients with Pancreatic Head Cancer. World J Surg. 2007;31(3):491-492.
• Narula VK, Watson WC, Davis SS, Hinshaw K, Needleman BJ, Mikami DJ, Hazey JW, Winston JH, Muscarella P, Rubin M, Patel V, and Melvin WS. A computerized analysis of robotic versus laparoscopic task performance. Surg Endosc. 2007;21(12):2258-2261.
• Hazey JW, Narula VK, Renton DB, Reavis KM, Paul CM, Hinshaw KE, Muscarella P, Ellison EC, and Melvin WS. Natural-orifice transgastric endoscopic peritoneoscopy in humans: Initial clinical trial. Surg Endosc. 2007;21(12):16-20.
• Tempero M, Alasadi R, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Bhargava P, Cameron JL, Casper ES, Hoffman JP, Kim P, Koh WJ, Kuvshinoff B, Malafa MP, Muscarella P 2nd, Nakakura EK, Sasson AR, Shibata S, Shrieve DC, Talamonti M, Tyler DS, Wang H, Warren RS, Willett C, Wolff RA. Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2007;5(10):998-1033.
• Varker KA, Muscarella P, Wall K, Ellison EC, Bloomston PM. Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World J Surg Oncol. 2007;27(5):145.
• Dundon JM, Davis SS, Hazey JW, Narula V, Muscarella P, and Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter (Stretta preocedure) does not provide long-term symptom control. Surg Innov. 2008;15(4):297-301.
• Muscarella P, Bloomston M, Brewer AR, Mahajan A, Frankel WL, Ellison EC, Farrar WB, Weghorst CM, and Li J. Expression of the p16INK4A/Ddkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens. Gene Expr. 2008;14:207-216.
• Dillhoff M, Yates R, Wall K, Muscarella P, Melvin WS, Ellison EC, and Bloomston M. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg. 2009;13(5):825-830.
• Bloomston M, Kneile J, Butterfield M, Dillhoff M, Muscarella P, Ellison EC, Melvin WS, Croce CM, Pichiorri F, Huebner K, and Frankel WL. Coordinate loss of fragile gene expression in pancreaticobiliary cancers: correlations among markers and clinical features. Ann Surg Oncol. 2009;16(8):2331-2338.
• Nau P, Melvin WS, Narula VK, Bloomston PM, Ellison EC, and Muscarella P. Laparoscopic distal pancreatectomy with splenic conservation: An operation without increased morbidity. Gastroenterol Res Pract. 2009:846340.
• Nau P, Anderson J, Yuh B, Muscarella P, Christopher Ellison E, Happel L, Narula VK, Melvin WS, and Hazey JW. Diagnostic transgastric endoscopic peritoneoscopy: extension of the initial human trial for staging of pancreatic head masses. Surg Endosc. 2010;24(6):1440-1446.
• Nau P, Clark CJ, Fisher MJ, Walker G, Needleman BJ, Ellison EC, and Muscarella P. Modified rives-stoppa repair for abdominal incisional hernias. Health. 2010;2(2):158-165.
• Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, and Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991-997.
• Nau P, Demyttenaere S, Muscarella P, Narula V, Hazey JW, Ellison EC, and Melvin WS. Pheochromocytoma does not increase risk in laparoscopic adrenalectomy. Surg Endosc. 2010;24(11):2760-2764.
• Jones NB, Hatzaras I, George N, Muscarella P, Ellison EC, Melvin WS, and Bloomston M. Clinical factors predictive of malignant and premalignant cystic neoplasms of the pancreas: a single institution experience. HPB. 2009;11(8):664-670.
• Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, and Bloomston M. Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB. 2010;12(2):134-138.
• Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW 2nd, Malafa MP, Muscarella P 2nd, Nakakura EK, Sasson AR, Thayer SP, Tyler DS, Warren RS, Whiting S, Willett C, and Wolff RA; NCCN Pancreatic Adenocarcinoma. Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2010;8(9):972-1017.
• Nau P, Ellison EC, Muscarella P Jr, Mikami D, Narula VK, Needleman B, Melvin WS, and Hazey JW. A review of 130 humans enrolled in transgastric NOTES protocols at a single institution. Surg Endosc. 2011;25(4):1004-11.
• Abdel-Misih SR, Hatzaras I, Schmidt C, Saab TB, Klemanski D, Muscarella P, Melvin WS, Ellison EC, and Bloomston M. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Ann Surg Oncol. 2011;18(4):1116-21.
• Hatzaras I, Schmidt C, Klemanski D, Muscarella P, Melvin WS, Ellison EC, and Bloomston M. Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg. 2011;212(3):373-7.
• Roland JC, Needleman BJ, Muscarella P, Cook CH, Narula VK, and Mikami DJ. Laparoscopic Roux-en-Y gastric bypass in patients with body mass index >70 kg/m2. Surg Obes Relat Dis. 2011;7(5):587-91.
• Nau P, Liu J, Ellison EC, Hazey JW, Henn M, Muscarella P, Narula VK, and Melvin WS. Novel reconstruction of the extrahepatic biliary tree with a biosynthetic absorbable graft. HPB (Oxford). 2011;13(8):573-8.
• Griesser MJ, Gillette B, Crist M, Pan X, Muscarella P, Scharschmidt T, and Mayerson J. Internal and External Hemipelvectomy or Flail Hip in Patients with Sarcomas: Quality-of-Life and Functional Outcomes. Am J Phys Med Rehabil. 2012;91(1):24-32.
• Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, and Shead DA; National Comprehensive Cancer Networks. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13.
• Li J, Knobloch TJ, Poi MJ, Zhang Z, Davis AT, Muscarella P, and Weghorst CM. Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells. Mol Carcinog. 2012 Oct 12. doi: 10.1002/mc.21965.
• Rath KS, Loseth D, Muscarella P, Phillips GS, Fowler JM, O'Malley DM, Cohn DE, Copeland LJ, Eisenhauer EL, and Salani R. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol.  2013 Apr;129(1):103-6. doi: 10.1016/j.ygyno.2013.01.021. Epub 2013 Jan 29.
• Drosdeck J, Carraro E, Arnold M, Perry K, Harzman A, Nagel R, Sinclair L, and Muscarella P. Porcine wet lab improves surgical skills in third year medical students. J Surg Res. 2013 Sep;184(1):19-25. doi: 10.1016/j.jss.2013.06.009. Epub 2013 Jun 28.
• Perry KA, Funk LM, Muscarella P, Melvin WS. Perioperative outcomes of laparoscopic transhiatal esophagectomy with antegrade esophageal inversion for high-grade dysplasia and invasive esophageal cancer. Surgery. 2013 Oct;154(4):901-7; discussion 907-8. doi: 10.1016/j.surg.2013.05.019. Epub 2013 Sep 3.
• Martin LK, Luu DC, Li X, Muscarella P, Christopher Ellison E, Bloomston M, Bekaii-Saab T. The Addition of Radiation to Chemotherapy does not Improve Outcome When Compared to Chemotherapy in the Treatment of Resected Pancreas Cancer: The Results of a Single-Institution Experience. Ann Surg Oncol. 2013 Sep 18.
• He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J, Wang J, Bloomston M, Muscarella P, Nau P, Shah N, Butchbach ME, Ladner K, Adamo S, Rudnicki MA, Keller C, Coletti D, Montanaro F, Guttridge DC. NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013 Oct 1. doi:pii: 68523. 10.1172/JCI68523.
• Collins A, Hatzaras I, Schmidt C, Carruthers K, Melvin WS, Muscarella P, Ellison EC, Martin E, Bloomston M. Gastrectomy in Advanced Gastric Cancer Effectively Palliates Symptoms and May Improve Survival in Select Patients. J Gastrointest Surg. 2013 Nov 15.
• Van Buren G, Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, Vollmer C, Velanovich V, Riall T, Muscarella P, Trevino J, Nakeeb A, Schmidt CM, Behrns K, Ellison EC, Barakat O, Perry KA, Drebin J, House M, Abdel-Misih S, Silberfein EJ, Goldin S, Brown K, Mohammed S, Hodges SE, McElhany A, Issazadeh M, Jo E, Mo Q, Fisher WE. A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage. Ann Surg. 2013 Dec 26.
• Perry KA, Kanji A, Drosdeck JM, Linn JG, Chan A, Muscarella P, Melvin WS. Efficacy and durability of robotic heller myotomy for achalasia: patient symptoms and satisfaction at long-term follow-up. Surg Endosc. 2014 May 31.
• Osayi SN, Bloomston M, Schmidt CM, Ellison EC, Muscarella P. Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review. Biomed Res Int. 2014 June 30.
• Osayi SN, Wendling MR, Drosdeck JM, Chaudhry UI, Perry KA, Noria SF, Mikami DJ, Needleman BJ, Muscarella P 2nd, Abdel-Rasoul M, Renton DB, Melvin WS, Hazey JW, Narula VK. Near-infrared fluorescent cholangiography facilitates identification of biliary anatomy during laparoscopic cholecystectomy. Surg Endosc. 2014 Jul 2.
• Poi MJ1, Drosdeck J, Frankel WL, Muscarella P, Li J. Deletions of RDINK4/ARF Enhancer in Gastrinomas and Nonfunctioning Pancreatic Neuroendocrine Tumors. Pancreas. 2014 Jul 7.
• Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. Pancreatic adenocarcinoma, version 2.2014. J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

Presentations:

• Evaluation of p16 Mutations in Gastrointestinal Neuroendocrine Tumors by “Cold” SSCP Analysis. Muscarella P, Foor J, Fisher WE, Melvin WS, Ellison EC, Hitchcock CL and Weghorst CM. Before The Americas Hepato-Pancreato-Biliary Congress, Miami, FL, February, 1997.
• Orally administered dehydroepiandrosterone inhibits the growth of subcutaneously injected pancreatic cancer cells in nude mice. Muscarella P, Boros L, Fisher WE and Melvin WS. Poster presentation at the Digestive Disease Week Annual Meeting, Washington, DC, May, 1997.
• An analysis of N-nitrosomethylbenzylamine-induced rat esophageal tumors for p16 mutations by ''Cold'' SSCP. Muscarella P, Chen J, Stoner GD, Melvin WS, and Weghorst CM. Poster presentation at the Digestive Disease Week Annual Meeting, Washington, DC, May, 1997.
• Genetic Alterations in Gastrinomas and Nonfunctioning Pancreatic Neuroendocrine Tumors: An Analysis of p16/MTS1 Tumor Suppressor Gene Inactivation. Muscarella P, Melvin WS, Fisher WE, Ellison EC, Schirmer WJ, Hitchcock CL, DeYoung BR, Herman JG and Weghorst CM. Before The Society of University Surgeons University Surgical Residents’ Conference, Milwaukee, WI, February, 1998.
• Genetic Alterations in Gastrinomas and Nonfunctioning Pancreatic Neuroendocrine Tumors: An Analysis of p16/MTS1 Tumor Suppressor Gene Inactivation. Muscarella P, Melvin WS, Fisher WE, Ellison EC, Schirmer WJ, Hitchcock CL, DeYoung BR, Herman JG and Weghorst CM. Poster presentation at the American Association for Cancer Research Meeting, New Orleans, LA, March, 1998.
• Partial Sequencing of the Syrian Golden Hamster p16/MTS1 Gene and Identification of an Inactivating Deletion in Hamster Pancreatic Tumor Cells. Muscarella P, Knobloch TJ, Melvin WS, Ellison EC and Weghorst CM. Poster presentation at the American Association for Cancer Research Meeting, New Orleans, LA, April, 2001.
• Deletional Inactivation of the p16/MTS1 Tumor Suppressor Gene in Hamster Pancreatic Tumors: Analysis by Multiplex Real-Time PCR. Muscarella P, Li J, Tsutsumi M, J Knobloch T, C Casto B, S Melvin W, M Weghorst C. J Gastrointestinal Surgery. 2003; 7(2):293. Poster presentation at the American Hepato-Pancreato-Biliary Meeting, Miami, FL, February, 2003.
• Endoscopic management of stomal stenosis after roux-en-y gastric bypass. Go MR, Muscarella P, Needleman BJ, Cook CH, Melvin WS. Surgical Endoscopy. 2003; 17(Suppl.):S197. Oral presentation at the Eighth World Congress of Endoscopic Surgery (SAGES), New York, N.Y., March, 2003.
• Diagnostic accuracy of serum CA19-9 concentrations in patients undergoing pancreatic resection. Sarah M. Cowgill, W. Scott Melvin, E.C. Ellison, and Peter Muscarella. Poster presentation at the Pancreas Club Meeting, Orlando, FL, May, 2003.
• Calmodulin Kinase IIαa in the Signal Transduction Pathway for Slow Synaptic Excitation in Enteric Neurons of Guinea Pig, Rat and Human Small IntestineNa Gao, Hong-Zhen Hu, Scott W. Arlin, Charles H. Cook, Bradley J. Needleman, Peter Muscarella II, Xiucai Fang, Yun Xia, Jackie D. Wood. Poster presentation at the American Gastroenterological Association Meeting, Orlando, FL, May, 2003.
• Post-surgical Pain Delays Healing of an Experimental Wound Authors. L. McGuire, J. Kiecolt-Glaser, R. Glaser, K. Heffner, B. Needleman, W. Malarkey, C. Cook, P. Muscarella, S. Melvin, C. Ellison. Poster presentation at the 2003 American Pain Association Annual Meeting.
• Diagnostic accuracy of serum Ca 19-9 in predicting malignancy in patients undergoing pancreatic resection. T. S. Bekaii-Saab, S. M. Cowgill, W. E. Burak, W. S. Melvin, E. C. Ellison, P. Muscarella. Poster presentation at the American Society of Clinical Oncology 2004 Gastrointestinal Cancer Symposium.
• Delivery of Radiofrequency Energy to the Lower Esophageal Sphincter (Stretta) Improves Symptoms of GERD. M.R. Go, J.M. Dundon, D.J. Karlowicz, C. Domingo, P. Muscarella, W.S. Melvin. Oral presentation before the Central Surgical Society. Chicago, IL, March, 2004.
• Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. Li J, Weghorst CM, Tsutsumi M, Poi MJ, Knobloch TJ, Casto BC, Melvin WS, Tsai M, and Muscarella P. Poster presentation before the American Pancreatic Association. Chicago, IL, November, 2004.
• A Structurally Optimized Celecoxib Derivative Inhibits Human Pancreatic Cancer Cell Growth. Junan Li, Jiuxiang Zhu, Ching-Shih Chen, W. Scott Melvin, and Peter Muscarella.  Poster presentation at the American Hepato-Pancreato-Biliary Meeting, Fort Lauderdale, FL, April, 2005.
• Novel Small Molecule Inhibitors for Pancreatic Cancer. Junan Li, Jiuxiang Zhu, Ching-shih Chen, W. Scott Melvin, and Peter Muscarella. Poster presentation at the American Association for Cancer Research Meeting, San Francisco, CA. April, 2005.
• Rives-Stoppa Retromuscular Repair for Incisional Hernias. Clark C, Fisher M, Walker G, and Muscarella P. Poster presentation at the Association for Academic Surgery meeting, San Diego, CA. February, 2006.
• Pancreatectomy for Non-Pancreatic Malignancies Results in Improved Survival after R0 Resection. Fisher M, Muscarella P, Ellison EC, and Bloomston M. Poster presentation before the American Pancreatic Association. Chicago, IL, November, 2006.
• Laparoscopic distal pancreatectomy with and without splenectomy: A retrospective review. Nau P, Bloomston PM, Melvin WS, Ellison EC, and Muscarella P. Oral quick shot presentation at the 4th Annual Academic Surgical Congress, Fort Myers, Fl. February, 2009.
• Laparoscopic distal pancreatectomy with and without splenectomy: A retrospective review. Nau P, Bloomston PM, Melvin WS, Ellison EC, and Muscarella P. Poster presentation at the 4th Annual Academic Surgical Congress, Fort Myers, Fl. February, 2009.
• Drosdeck JM, Carraro EA, Arnold MW, Perry KA, Harzman AE, Nagel R, Sinclair LM, and Muscarella P.  Porcine wet lab improves surgical skills in third year medical students. Oral presentation before the Academic Surgery Congress. New Orleans, LA, Feb. 2013.
• Donald A. Richards, MD, PhD, Peter Muscarella, MD, Tanios Bekaii-Saab, MD, Lalan S. Wilfong, MD, Alexander Rosemurgy, MD, Sharona B. Ross, MD, Julian Raynov, MD, PhD, Patrick J. Flynn, MD, William E. Fisher, MD, Sam H. Whiting, MD, PhD, Constanta Timcheva, MD, PhD, Frank E. Harrell Jr., PhD, Nathaniel D.
• Mercaldo, MS, Tom N. Holmes, MS, Joanna Roder, PhD, Heinrich Roder, DPhil, Sue Speyer, RN, BA, Joni Richman, RN, BSN, Claire Coeshott, PhD, Allen Cohn, MD, John Ferraro, MBA, Timothy C. Rodell, MD, FCCP, David Apelian, MD, PhD, MBA. A PHASE 2 ADJUVANT TRIAL OF GI-4000 PLUS GEM VS. GEM ALONE IN RAS MUTATION+ RESECTED PANCREAS CANCER: R1 SUBGROUP AND PROTEOMIC ANALYSIS. Oral presentation before the European Society for Medical Oncology 14th World Congress. June, 2012.

Genbank Submissions

• Mesocricetus auratus cyclin-dependent kinase inhibitor 2 mRNA, complete cds. Accession number: AF292567. January 28, 2001.
• Mesocricetus auratus cyclin-dependent cell cycle inhibitor gene, exon 1. Accession number: AF291997. January 28, 2001.
• Mesocricetus auratus cyclin-dependent cell cycle inhibitor gene, exon 2 and partial cds. Accession number: AF291998. January 28, 2001.
• Mesocricetus auratus cyclin-dependent kinase inhibitor 2 mRNA, complete cds. Accession number: AF292567. November 15, 2001.
• Mesocricetus auratus mRNA for p15INK4b cyclin-dependent kinase inhibitor (p15INK4b gene). Accession number: AF292567. November 17, 2001.